Skip to main content
Equibles
CRSP logo

CRSP · CRISPR Therapeutics AG

Track CRSP — free

Use CRSP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CRSP

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$59.50 +1.38 (+2.37%) At close · Aug 21
Market Cap
$5.75B
Shares
96.69M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
18,697,820 -0.6% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
83/100
Short interest 19.5% of shares — P98 Days to cover 11.5 — P91 Price vs VWAP +12.0% — P82 Short-volume trend +3.3% — P64 Short interest change -5.0% — P38 Worst FTD 0.48% of shares — P94

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 18,815,663 19,808,194 -992,531 11.52
    2026-07-15 19,808,194 20,397,833 -589,639 11.56
    2026-06-30 20,397,833 26,572,400 -6,174,567 11.65
    2026-06-15 26,572,400 21,672,640 +4,899,760 16.35
    2026-05-29 21,672,640 27,293,997 -5,621,357 12.29
    2026-05-15 27,293,997 22,484,150 +4,809,847 16.54
    2026-04-30 22,484,150 22,752,661 -268,511 11.91
    2026-04-15 22,752,661 22,618,060 +134,601 15.30
    2026-03-31 22,618,060 21,686,413 +931,647 13.23
    2026-03-13 21,686,413 21,562,457 +123,956 7.63
    2026-02-27 21,562,457 22,638,749 -1,076,292 14.31
    2026-02-13 22,638,749 21,888,419 +750,330 13.21
    2026-01-30 21,888,419 21,739,501 +148,918 12.10
    2026-01-15 21,739,501 21,051,418 +688,083 11.92
    2025-12-31 21,051,418 21,863,725 -812,307 14.19
    2025-12-15 21,863,725 22,431,985 -568,260 12.30
    2025-11-28 22,431,985 23,186,755 -754,770 9.25
    2025-11-14 23,186,755 21,033,230 +2,153,525 8.57
    2025-10-31 21,033,230 21,048,713 -15,483 9.89
    2025-10-15 21,048,713 21,354,942 -306,229 6.79
    2025-09-30 21,354,942 23,811,876 -2,456,934 7.70
    2025-09-15 23,811,876 22,074,375 +1,737,501 12.63
    2025-08-29 22,074,375 23,309,013 -1,234,638 12.70
    Showing 1–23 of 23 settlements
    Key facts CIK 1674416 CUSIP H17182108 13F (30d) 429 filings 417 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)